https://estronechemical.com/gu....essing-nitrogen-base
They have also demonstrated efficacy in HER2-negative metastatic breast cancer tumors and advanced prostate cancer with BRCA1/2 or ATM mutations. Patients with somatic and/or germline BRCA1/2 mutations benefit more from these treatments than other customers. Nowadays, the diagnosis of HRD is basically considering germline genetic evaluation, that will be performed after an in-person genetic counseling session, also for
Like
Comment
Share
